Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels

European Respiratory Journal

Volumn 19, Issue 5, 2002, Pages 952-958

  Yang, B ^a   Yao, D F ^a   Ohuchi, M ^a   Ide, M ^a   Yano, M ^a   Okumura, Y ^a   Kido, H ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Ambroxol; Cytokine; Immunoglobulin A; Influenza A virus; Mucus protease inhibitor; Pulmonary surfactant protein A

Indexed keywords

AMBROXOL; ANTIVIRUS AGENT; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 12; MUCOLYTIC AGENT; PROTEINASE INHIBITOR; SURFACTANT PROTEIN A; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; EXPECTORANT AGENT; IMMUNOGLOBULIN; LUNG SURFACTANT;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HOST RESISTANCE; INFLUENZA VIRUS A; LUNG FLUID; LUNG LAVAGE; MOUSE; MUCUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RESPIRATORY TRACT INFECTION; SURVIVAL RATE; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TITRATION; ANIMAL; CHEMISTRY; DRUG EFFECT; EVALUATION; ORTHOMYXOVIRUS; ORTHOMYXOVIRUS INFECTION; PHYSIOLOGY; SURVIVAL;

AMBROXOL; ANIMAL; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; EXPECTORANTS; IMMUNOGLOBULINS; MICE; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; PULMONARY SURFACTANTS; RESPIRATORY TRACT INFECTIONS; SUPPORT, NON-U.S. GOV'T; SURVIVAL ANALYSIS; VIRUS REPLICATION; ANIMALS;

EID: 0036014553     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.02.00253302     Document Type: Article

References (29)

1. Influenza A and B virus infection in infants and young children during the years 1957-1976
2. Impact of epidemic type A influenza in a defined adult population
3. Host cell proteases controlling virus pathogenicity
4. The molecular biology of influenza virus pathogenicity
5. Trypsin action on the growth of Sendai virus in tissue culture cells
6. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells
7. Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity
8. Human Mucus protease inhibitor in airway fluids is a potential defensive compound against infection with influenza A and Sendai viruses
9. A pulmonary surfactant is a potential endogenous inhibitor of proteolytic activation of Sendai virus and influenza virus
10. Interactions of surfactant protein A with influenza A viruses: Binding and neutralization
11. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA rather than serum antibody or cytotoxic T cell reactivity
12. Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza
13. Secretory immunological response after intranasal inactivated influenza A virus vaccinations: Evidence for immunoglobulin A memory
14. Clinical efficacy of ambroxol in the treatment of bronchial stasis
15. The inhibition of lysosomal phospholipase A from rabbit lung by ambroxol and its consequences for pulmonary surfactant
16. Oxidant scavenger function of ambroxol in vitro: A comparison with N-acetylcysteine AC
17. Reduction of cytokine release from blood and bronchoalveolar mononuclear cells by ambroxol
18. Ambroxol inhibits the release of histamine, leukotriemes and cytokines from human leukocytes and mast cells
19. The history of the "deutche Maus" the origin of the dd mouse group
20. Aprotinin aerosol treatment of influenza and paramyxovirus broncho-pneumonia of mice
21. Pneumotropism of Sendai virus in relation to protease mediated activation in mouse lungs
22. An immunologic study of the secretory products of rat clara cells
23. Murine pulmonary surfactant SP-A: Gene cloning, sequence, and transcripitional activity
24. Characterization of the rat pulmonary surfactant protein A promoter
25. Effects of a pulmonary surfactant and surfactant protein A on phagocytosis of fractionated alveolar macrophages: Relationship to starvation
26. Apocynin improves the efficacy of a secretory leukocyte protease inhibitor in experimental emphysema
27. Isolation and partial characterization of a low molecular weight acid stable protease inhibitor from human bronchial secretions
28. Cellular proteinases trigger the infectivity of the influenza A and Sendai viruses
29. IL-12 is an effective adjuvant for induction of mucosal immunity